NUVB
Nuvation Bio Inc. Class A
Latest News for NUVB
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Nuvation Bio (NUVB), Spyre Therapeutics (SYRE) and N......
Wedbush analyst David Nierengarten maintained a Buy rating on Nuvation Bio today and set a price target of $11.00. According to TipRanks, Nierengar......
RBC Capital analyst Leonid Timashev maintained a Buy rating on Nuvation Bio on April 6 and set a price target of $20.00. The company’s shares close......
In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Nuvation Bio, with a price target of $12.00. Roy covers the Hea......
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Nuvation Bio (NUVB) and Eli Lilly & Co (LLY) with bu......
Wedbush analyst David Nierengarten maintained a Buy rating on Nuvation Bio today and set a price target of $11.00. Nierengarten covers the Healthca......
News data is sourced from MarketXLS API and updated regularly.
Showing 6 of 6 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NUVB | $4.89 | -3.0% | 4.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Nuvation Bio Inc. Class A Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW